{"product_id":"tesamorelin-peptide-intelligence-monograph","title":"Tesamorelin — Peptide Intelligence Monograph","description":"\u003ch3 class=\"PDq2pG_selectionAnchorContainer\"\u003eShort description\u003cspan class=\"PDq2pG_selectionAnchor\"\u003e\u003c\/span\u003e\n\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eThe Evidence Behind the Hype.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA physician-reviewed, evidence-based examination of tesamorelin from the Founder’s Institute of Medicine \u0026amp; Education.\u003c\/p\u003e\n\u003cp\u003eUnlike many peptides promoted in the wellness marketplace, tesamorelin has been evaluated in randomized human clinical trials and has an FDA-approved therapeutic indication. This monograph examines what those studies actually demonstrate—and where extrapolation beyond the evidence begins.\u003c\/p\u003e\n\u003ch3\u003eFull product description\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eTesamorelin has unusually strong human evidence for a peptide discussed in contemporary longevity and metabolic medicine. But that does not mean every claim made about it is supported.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTesamorelin is a synthetic growth hormone–releasing factor analog developed to stimulate endogenous growth hormone secretion. Its clinical development produced randomized controlled human trials and ultimately FDA approval for reduction of excess abdominal fat in HIV-infected adults with lipodystrophy.\u003c\/p\u003e\n\u003cp\u003eThat evidence provides an unusually substantial clinical foundation compared with many peptides currently promoted online.\u003c\/p\u003e\n\u003cp\u003eIt also creates an important scientific question:\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhich conclusions are actually supported by the clinical literature—and which claims represent extrapolation beyond the populations, endpoints, and indications that have been studied?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe Founder’s Institute Peptide Intelligence Monograph examines tesamorelin through that distinction.\u003c\/p\u003e\n\u003ch3\u003eInside the monograph\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eMolecular identity and pharmacologic classification\u003c\/li\u003e\n\u003cli\u003eGrowth hormone–releasing hormone receptor physiology\u003c\/li\u003e\n\u003cli\u003eGH\/IGF-1 axis and downstream biological effects\u003c\/li\u003e\n\u003cli\u003eHuman randomized controlled trial evidence\u003c\/li\u003e\n\u003cli\u003eEvidence surrounding visceral adipose tissue\u003c\/li\u003e\n\u003cli\u003eMetabolic and body-composition findings\u003c\/li\u003e\n\u003cli\u003eFDA-approved indication and regulatory context\u003c\/li\u003e\n\u003cli\u003eSafety findings and clinically relevant limitations\u003c\/li\u003e\n\u003cli\u003eDistinction between approved use and broader off-label claims\u003c\/li\u003e\n\u003cli\u003eClaim-by-claim \u003cstrong\u003eFIPES evidence grading\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003eWhat we know, what we do not know, and what research is still needed\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003ePhysician reviewed. Evidence graded. No protocols. No dosing instructions. No promotional claims.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis publication is intended for education and scientific evidence review. It is not medical advice and does not recommend or instruct the use of tesamorelin.\u003c\/p\u003e","brand":"Founder's Institute of Medicine \u0026 Education","offers":[{"title":"Default Title","offer_id":45379665133750,"sku":null,"price":24.95,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0736\/0990\/4310\/files\/ChatGPTImageAug26_2026_09_27_52PM.png?v=1787808558","url":"https:\/\/foundersinstitutemed.org\/products\/tesamorelin-peptide-intelligence-monograph","provider":"Founder's Institute of Medicine \u0026 Education","version":"1.0","type":"link"}